NORTH-REG has as ultimate objective to become the Nordic epicenter of multicenter studies where the vast majority of all bladder cancer patients in a very large catchment area covering several countries can be included in large scale clinical trials. This set-up ensures fast and valid results that can very easily be incorporated in future guidelines shortly after reporting of the results in high impact scientific papers.

NORTH-REG has the ability to perform all trials from Phase I, II and III trials to Phase IV trials as the total patient volume is very high and even small subgroups will have a substantial number of patients included in the cohort. The unique national data of the Nordic countries and uniform guidelines makes the perfect set-up for epidemiological and clinical studies.